HopeStage
Back to all studies
RecruitingNCT04296097

Evaluation of Deep Brain Stimulation (DBS) of the Right Operculum 3 (OP3) in Permanent Non-pulsatile Disabling Tinnitus (TINNOP3-DBS)

Device studyAges 18–75FranceAnxiety
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 75 years.

Listed locations
GrenobleSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: April 23, 2021
Recruitment status
Recruiting
Enrollment listed in the registry
7
Sponsor
University Hospital, Grenoble
Sponsor type
Hospital / academic medical center
Study type
Device
Intervention type
Device
Locations
France
Age range
From 18 Years to 75 Years
Official registry ID
NCT04296097
Official title
Show the full official title

Evaluation of Deep Brain Stimulation (DBS) of the Right Operculum 3 (OP3) in Permanent Non-pulsatile Disabling Tinnitus (TINNOP3-DBS)

Recruitment & locations

Currently recruiting

Grenoble

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University Hospital, Grenoble, a hospital or academic medical center.

Who can participate?

Listed age limits: 18 years to 75 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies